Inventor · disambiguated record
Charles Bell
Also filed as: BELL CHARLES
4 granted patents·5 pending applications·14 citations·filing 2020–2023
70Inventor score
Files withHOFFMANN LA ROCHE9
Top patents by PatentIndex Score
9 records- 0194US11420961B2Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2020·Granted Aug 23, 2022·6 cites·19 claims
- 0292US11802133B2Heterocyclic compounds as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2022·Granted Oct 31, 2023·2 cites·10 claims
- 0392US11390610B2Piperazine derivatives as MAGL inhibitorsHOFFMANN LA ROCHE·Filed 2020·Granted Jul 19, 2022·6 cites·38 claims
- 0481US12281124B2Heterocyclic compounds as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2023·Granted Apr 22, 2025·0 cites·20 claims
- 0570US2023183224A1Bezoxazine derivatives useful as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0666US2023117324A1Oxazine monoacylglycerol lipase (magl) inhibitorsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0765US2020308190A1Heterocyclic compounds as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0858US2021107920A1Oxazine monoacylglycerol lipase (magl) inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0957US2020308158A1Bezoxazine derivatives useful as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charles Bell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →